Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04646616 · ClinicalTrials.gov registry record · NA
CRISOL Contigo: a Multi-level Intervention to Reduce the Disproportionate Toll of COVID-19 Among Latino Communities in Philadelphia.
A NA study, sponsored by Drexel University.
- Completed
- Registry status
- NA
- Development phase
- 178
- Enrollment target
NCT04646616 is a NA study that has completed, run by Drexel University. The registered enrollment target is 178 participants.
The verdict
NCT04646616, a NA study, has completed, sponsored by Drexel University.
- COMPLETED
- Registry status
- NA
- Development phase
- 178 participants
- Enrollment target
Study Summary
Latinos have been one of the racial/ethnic groups most impacted by the COVID-19 pandemic, and evidence of effective strategies to curb the pandemic, reduce disparities, and mitigate its impact is lacking and very urgent. The goal of this competitive revision is to expand an ongoing academic-community partnership to adapt, implement, and evaluate a multi-level intervention to mitigate the multi-dimensional toll of COVID19 among Latino immigrant communities in Philadelphia.
Interventions
- OTHER Community popular opinion leader (POL) based intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2021-01-15 |
| Est. Completion | 2022-03-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04646616
The ClinicalTrials.gov registry entry for NCT04646616 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Drexel University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Community popular opinion leader (POL) based intervention is the first listed.
NCT04646616 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04646616 about?
NCT04646616 is a clinical study titled "CRISOL Contigo: a Multi-level Intervention to Reduce the Disproportionate Toll of COVID-19 Among Latino Communities in Philadelphia.". Latinos have been one of the racial/ethnic groups most impacted by the COVID-19 pandemic, and evidence of effective strategies to curb the pandemic, reduce disparities, and mitigate its impact is lacking and very urgent. The goal of this competitive revision is to expand an ongoing academic-communi...
What is the current status of trial NCT04646616?
This trial is currently completed. It is a NA study. The enrollment target is 178 participants. The study started on 2021-01-15. Estimated completion is 2022-03-04.
What interventions are being tested in trial NCT04646616?
The interventions under investigation include: Community popular opinion leader (POL) based intervention (OTHER).
Who is sponsoring clinical trial NCT04646616?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.